Picture of Innate Pharma SA logo

IPHA Innate Pharma SA News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

U.S. RESEARCH ROUNDUP- Alphabet, Facebook, Goldman Sachs

Sept 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Alphabet, Facebook and Goldman Sachs on Friday. 
    
  HIGHLIGHTS        
     * Alphabet Inc  GOOGL.O : Jefferies raises target price to $3,325 from $3,150
     * Facebook Inc  FB.O : Jefferies raises target price to $440 from $425
     * Goldman Sachs  GS.N : JP Morgan raises target price to $458 from $455
     * Las Vegas Sands Corp  LVS.N : Jefferies cuts target price to $40 from $60
     * National Retail Properties Inc  NNN.N : RBC initiates with sector perform rating and $48 PT
                
Following is a summary of research actions on U.S. companies reported by Reuters on Friday.
Stock entries are in alphabetical order.         
     * Agiliti Inc  AGTI.N : Raymond James raises target price to $25 from $22.50
     * Agree Realty Corp  ADC.N : RBC initiates with outperform rating and $80 target price
     * Alphabet Inc  GOOGL.O : Jefferies raises target price to $3,325 from $3,150
     * Antero Resources Corp  AR.N : Truist Securities raises target price to $18 from $16
     * Autoliv Inc  ALV.N : Exane BNP Paribas cuts to underperform from neutral
     * Curiositystream Inc.  CURI.O : JP Morgan initiates with overweight rating and PT of $15
     * Eastgroup Properties Inc  EGP.N : Jefferies raises target price to $173 from $170
     * Facebook Inc  FB.O : Jefferies raises target price to $440 from $425
     * Ferrari  RACE.N : Exane BNP Paribas cuts to neutral from outperform
     * Getty Realty Corp  GTY.N : RBC initiates with sector perform rating and $31 target price
     * Goldman Sachs  GS.N : JP Morgan raises target price to $458 from $455
     * Great Western Bancorp Inc  GWB.N : RBC cuts target price to $33 from $35
     * Great Western Bancorp Inc  GWB.N : RBC cuts to sector perform from outperform
     * Home Bancshares Inc  HOMB.O : Stephens raises target price to $29 from $27
     * Illumina Inc  ILMN.O : CFRA cuts to hold from buy; cuts target price by $62 to $460
     * Innate pharma SA  IPHA.O : SVB Leerink raises target price to $9 from $7
     * Integral Ad Science Holding Corp  IAS.O : Jefferies raises target price to $28 from $23
     * Las Vegas Sands Corp  LVS.N : Jefferies cuts to hold from buy
     * Las Vegas Sands Corp  LVS.N : Jefferies cuts target price to $40 from $60
     * Lexington Realty Trust  LXP.N : Jefferies raises target price to $16 from $15
     * Lululemon Athletica Inc  LULU.O : Oppenheimer raises target price to $520 from $405
     * Magellan Midstream Partners LP  MMP.N : Citigroup cuts price target to $51 from $56
     * Murphy USA Inc  MUSA.N : Stephens raises target price to $220 from $195
     * National Beverage Corp  FIZZ.O : Jefferies raises target price to $51 from $45
     * National Retail Properties Inc  NNN.N : RBC initiates with sector perform rating and $48 PT
     * Realty Income Corp  O.N : RBC initiates with outperform rating and $79 target price
     * Silverback Therapeutics Inc  SBTX.O : SVB Leerink cuts target price to $42 from $49
     * Spirit Realty Capital Inc  SRC.N : RBC initiates with sector perform rating and $53 PT
     * Stag Industrial Inc  STAG.N : Jefferies raises target price to $47 from $45
     * Stitch Fix Inc  SFIX.O : JP Morgan cuts target price to $45 from $52
     * Sunnova Energy International Inc  NOVA.N : Evercore ISI cuts target price to $53 from $55
     * Terreno Realty Corp  TRNO.N : Jefferies raises target price to $79 from $77
     * USANA Health Sciences Inc  USNA.N : Jefferies cuts target price to $90 from $100
     * Viper Energy Partners LP  VNOM.O : Keybanc raises target price to $21 from $20
     * WP Carey Inc  WPC.N : RBC initiates with outperform rating and $89 target price
     * Wynn Resorts Ltd  WYNN.O : Jefferies cuts target price to $83 from $104
     * Zymeworks Inc  ZYME.N : JP Morgan raises target price to $39 from $36
     * Zymeworks Inc  ZYME.N : SVB Leerink raises target price to $43 from $41
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Innate Pharma SA

See all news